The pharmaceutical manufacturing sector puts science into action to produce and distribute life-saving and enhancing medical treatments. Society relies on the skills of this workforce to create safe and reliable products for both human and animal use, including molecular medicines, biologic drugs, and complimentary products such as vitamins, supplements, and sunscreens. While the 2020 COVID-19 pandemic has presented challenges to many workforces, it has also reaffirmed how important it is that Australia has access to up to date skills standards in pharmaceutical manufacture, providing access to the skills needed to get medicines to those who need them.
The Pharmaceutical Manufacturing Industry Reference Committee (IRC) has been operating as needed since December 2017, as an extension of the Food, Beverage and Pharmaceutical IRC.
The pharmaceutical manufacturing industry covers the following sectors:
- Medicine manufacturing (Biologics)
- Medicine manufacturing (Molecule)
- Complementary medicine manufacturing
- Vitamin and mineral supplements manufacturing
- Nutrition supplements manufacturing
- Skin care, sunscreen and topical pharmaceutical manufacturing
- Natural products
- Veterinary pharmaceutical manufacturing/ regulation
Want to know more about the work to improve skills standards for this industry?
Industry trends, challenges and opportunities are gathered through consultation with industry and research. They are documented in Skills Forecasts, which the Australian Industry and Skills Committee considers to determine future training package (skills standards) projects. Each project is overseen by the relevant Industry Reference Committee (IRC) and managed by Skills Impact. Click on the menu to the left for more information about the IRC, current projects, Skills Forecasts, as well as current units, skill sets and qualifications within the Training Package.